LIN.US

417.52

-1.34%↓

SCCO

127

-2.85%↓

NEM

87.05

-0.76%↓

SHW

327.06

-1.5%↓

AEM

164.83

-1.84%↓

LIN.US

417.52

-1.34%↓

SCCO

127

-2.85%↓

NEM

87.05

-0.76%↓

SHW

327.06

-1.5%↓

AEM

164.83

-1.84%↓

LIN.US

417.52

-1.34%↓

SCCO

127

-2.85%↓

NEM

87.05

-0.76%↓

SHW

327.06

-1.5%↓

AEM

164.83

-1.84%↓

LIN.US

417.52

-1.34%↓

SCCO

127

-2.85%↓

NEM

87.05

-0.76%↓

SHW

327.06

-1.5%↓

AEM

164.83

-1.84%↓

LIN.US

417.52

-1.34%↓

SCCO

127

-2.85%↓

NEM

87.05

-0.76%↓

SHW

327.06

-1.5%↓

AEM

164.83

-1.84%↓

Search

Balchem Corp

Закрыт

СекторСырье

155.45 -0.41

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

153.1

Макс.

156.4

Ключевые показатели

By Trading Economics

Доход

2M

40M

Продажи

12M

268M

P/E

Средняя по отрасли

33.967

79.657

Прибыль на акцию

1.35

Дивидендная доходность

0.57

Рентабельность продаж

15.058

Сотрудники

1,355

EBITDA

11M

74M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+21.21% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

0.57%

3.27%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

134M

5B

Предыдущая цена открытия

155.86

Предыдущая цена закрытия

155.45

Новостные настроения

By Acuity

50%

50%

86 / 166 Рейтинг в Basic materials

Техническая оценка

By Trading Central

Уверенность

Very Strong Bullish Evidence

Balchem Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

17 нояб. 2025 г., 18:59 UTC

Главные движущие силы рынка

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17 нояб. 2025 г., 23:40 UTC

Обсуждения рынка

Gold Consolidates Amid Mixed Signals -- Market Talk

17 нояб. 2025 г., 23:34 UTC

Обсуждения рынка

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17 нояб. 2025 г., 22:58 UTC

Обсуждения рынка

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17 нояб. 2025 г., 22:46 UTC

Обсуждения рынка

Risk Assets Set to Have a Strong 2026 -- Market Talk

17 нояб. 2025 г., 22:06 UTC

Приобретения, слияния, поглощения

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17 нояб. 2025 г., 22:02 UTC

Отчет

Trip.com Group 3Q Rev $2.6B >TCOM

17 нояб. 2025 г., 22:02 UTC

Отчет

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17 нояб. 2025 г., 22:02 UTC

Отчет

Trip.com Group 3Q EPS $4.02 >TCOM

17 нояб. 2025 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

17 нояб. 2025 г., 21:40 UTC

Отчет

James Hardie Industries 2Q Adj EPS 26c >JHX

17 нояб. 2025 г., 21:40 UTC

Отчет

James Hardie Industries 2Q Loss/Shr 10c >JHX

17 нояб. 2025 г., 21:39 UTC

Отчет

James Hardie Industries 2Q Sales $1.29B >JHX

17 нояб. 2025 г., 21:38 UTC

Отчет
Приобретения, слияния, поглощения

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 нояб. 2025 г., 21:38 UTC

Отчет

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17 нояб. 2025 г., 21:10 UTC

Отчет

XP Inc. 3Q EPS BRL2.47 >XP

17 нояб. 2025 г., 21:10 UTC

Отчет

XP Inc. 3Q Rev BRL4.67B >XP

17 нояб. 2025 г., 20:20 UTC

Обсуждения рынка

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17 нояб. 2025 г., 20:12 UTC

Обсуждения рынка

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17 нояб. 2025 г., 20:12 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

17 нояб. 2025 г., 20:09 UTC

Обсуждения рынка

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17 нояб. 2025 г., 19:29 UTC

Обсуждения рынка

Gold Slide Continues to Start Week -- Market Talk

17 нояб. 2025 г., 19:16 UTC

Отчет
Приобретения, слияния, поглощения

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 нояб. 2025 г., 18:20 UTC

Приобретения, слияния, поглощения

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17 нояб. 2025 г., 16:45 UTC

Приобретения, слияния, поглощения

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17 нояб. 2025 г., 16:16 UTC

Отчет
Приобретения, слияния, поглощения

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 нояб. 2025 г., 16:15 UTC

Отчет

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17 нояб. 2025 г., 15:40 UTC

Приобретения, слияния, поглощения

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17 нояб. 2025 г., 15:22 UTC

Приобретения, слияния, поглощения

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17 нояб. 2025 г., 15:19 UTC

Обсуждения рынка

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Сравнение c конкурентами

Изменение цены

Balchem Corp Прогноз

Целевая цена

By TipRanks

21.21% рост

Прогноз на 12 месяцев

Средняя 190 USD  21.21%

Максимум 190 USD

Минимум 190 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для Balchem Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

1 ratings

1

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

157.75 / 166.25Поддержка и Сопротивление

Краткосрочная

Very Strong Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Strong Bearish Evidence

Настроения

By Acuity

86 / 166Рейтинг в Сырье

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Balchem Corp

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
help-icon Live chat